Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer. - Wikidata - thesis-toulmin - TriplyDB

Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.

Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.

http://www.wikidata.org/entity/Q54574332

about

Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers.Evolutionary history of the cancer immunity antigen MAGE gene family.A novel cancer/testis antigen KP-OVA-52 identified by SEREX in human ovarian cancer is regulated by DNA methylation Cancer-testis (CT) antigen expression in medulloblastoma.Prolonged survival of patients with lung adenocarcinoma expressing XAGE-1b and HLA class I antigens MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition.Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.Myeloid-derived suppressor cells enhance the expression of melanoma-associated antigen A4 in a Lewis lung cancer murine model Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer.Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer.MAGE-A Antigens and Cancer Immunotherapy.Cancer testis antigens: a novel target in lung cancer.Beyond chemotherapy and targeted therapy: adoptive cellular therapy in non-small cell lung cancer.New York esophageal squamous cell carcinoma-1 and cancer immunotherapy.MAGE-A3: an immunogenic target used in clinical practice.Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.Expression of cancer/testis antigens MAGE-A, MAGE-C1, GAGE and CTAG1B in benign and malignant thyroid diseases.MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas.Antibody response against cancer-testis antigens MAGEA4 and MAGEA10 in patients with melanoma.SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes.

P2860

Q33555751-903020C3-61FD-440C-ABCB-2304FB2A31C8 Q33939709-042B22AF-6832-4934-B821-53AD837F2B42 Q34087776-D6A5E6FD-50CE-41E9-A012-8B5EE3C3ABEC Q34111864-C7A97495-8D5E-440F-8738-0E4317D9EF70 Q34111868-732388DD-90B5-4130-8454-880BF85B06ED Q34196069-5FCA9F3E-B6AA-410A-8E65-175E3EC83D7E Q34823783-65C0512E-6454-4EFF-965A-3856B6E193E7 Q35011313-C49DD044-DBEB-4940-BDE4-0D93E6BB2E26 Q35050623-D36011C9-ADB8-4528-95A3-603B63D6A0F1 Q35273882-135339F0-4A3F-47D0-92D2-2F5C176EFBDE Q35854237-8237602F-1B4B-4869-9FBD-C9035D8725F4 Q36503123-E81B965F-46F6-46FE-BEEB-FB71121BEE69 Q36637039-09F93449-5C9C-4A20-ADC2-F182A8276E22 Q36785925-39974B05-6AED-439C-BE3A-3BD57762146B Q37598077-E49636E7-80C6-487B-830A-584A6DA754F3 Q37685379-4031AFA4-12C4-4B4D-8F60-8C647BD0E21A Q38053489-83AEEF50-A791-464B-8526-E65884C1E649 Q38223594-7D14B935-3F22-4E5F-B3BE-89040A686A9F Q38445350-95B0A378-E3C8-4D67-9552-228BDE0E1793 Q38534721-F095837E-CF66-41D8-B605-595EE6327F0C Q38948541-CECFA564-08C4-441B-AA70-3FE85B4AFB8B Q47199295-248B42A6-347B-43C7-891E-A209432F4D42 Q54284949-D988291A-9B9A-4075-BDBA-7AE1317BF969 Q55241840-0CBACF0E-D388-41FA-BD74-3F83F9E9001D Q55342016-C88B486D-F01D-4B94-9039-A17A4EF26D3F

P2860

Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.

http://www.wikidata.org/entity/Q54574332

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Cancer/testis antigen expressi ...... in non small cell lung cancer.

@en

Cancer/testis antigen expressi ...... in non small cell lung cancer.

@nl

type

label

Cancer/testis antigen expressi ...... in non small cell lung cancer.

@en

Cancer/testis antigen expressi ...... in non small cell lung cancer.

@nl

prefLabel

Cancer/testis antigen expressi ...... in non small cell lung cancer.

@en

Cancer/testis antigen expressi ...... in non small cell lung cancer.

@nl

P1433

Q54574332-8625079C-9511-4D8A-9CE5-B666CF445BF0

P1476

Q54574332-0273B818-FCFE-4ABF-B209-BC5A542A2A88

P2093

Q54574332-62FD0C87-D793-4206-9B63-4601FD0581DC

Q54574332-762A54A3-3B84-4DFE-8EB6-D99C99F1378C

Q54574332-7CEA5526-519B-40E0-95FD-DBA2317FFB3D

Q54574332-9C7D7ABB-4285-4BFF-9162-D56EE5BEB16C

Q54574332-A64BCA1F-225F-41A3-A1D8-F8977DF89446

Q54574332-B255CD30-CDBC-4E82-92A3-95F7202EB851

Q54574332-E591BEDD-ED91-471A-8809-8865CCF431B8

P2860

Q54574332-0725C334-8BB0-4C2F-9173-7D2722B019D0

Q54574332-341F7D6D-1E8F-4E60-A37C-1C4B9F35BE18

Q54574332-344BBCDB-A28E-4179-B19A-A5D7511D81B5

Q54574332-9CAC18BE-8BC2-4AAC-936C-98F539893EEC

Q54574332-F29F46C7-0A42-4A5F-B1C0-0E461DBEF597

Q54574332-FF97BE83-62AA-4FB7-89E4-08AD5FF94010

P304

Q54574332-5D7BBD5C-1B39-41D1-AD7C-4AABD02CEB31

P31

Q54574332-1A75AE65-8B58-4A47-8EBF-669864DBB354

P356

Q54574332-FA59DE51-9979-4A01-BA8F-7F9FA19C271D

P433

Q54574332-A0C88980-9470-4FE7-BD7C-981BC0FA5069

P478

Q54574332-5739F523-ABD5-4458-B9A3-A4DFC03F811B

P50

Q54574332-6B40A0A2-23EB-4E80-B48B-49B2EC91ABA3

Q54574332-BC351C13-BC9D-4A20-8FAB-1D6AA2D75DDE

P577

Q54574332-BFDD666D-3F89-4A02-86FA-FA2F54FC418B

P5875

Q54574332-4DB8F12D-3D26-495C-97C4-E0DD60694EB0

P698

Q54574332-53237994-0B57-4F4F-8380-1349A7B9F0D2

P921

Q54574332-416EF1CE-8D39-4857-824A-DC13B46F84A6

Q54574332-B9415A3A-E808-4010-9197-F56C6A033677

P356

P1433

International Journal of Cancer

P1476

Cancer/testis antigen expressi ...... in non small cell lung cancer.

@en

P2093

Célia Groeper

http://www.w3.org/2001/XMLSchema#string

Franco Gambazzi

http://www.w3.org/2001/XMLSchema#string

Giulio C Spagnoli

http://www.w3.org/2001/XMLSchema#string

Hans-Reinhard Zerkowski

http://www.w3.org/2001/XMLSchema#string

Lukas Bubendorf

http://www.w3.org/2001/XMLSchema#string

Michael Heberer

http://www.w3.org/2001/XMLSchema#string

Rachel Rosenthal

http://www.w3.org/2001/XMLSchema#string

P2860

The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ

MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma.

Mature dendritic cells prime functionally superior melan-A-specific CD8+ lymphocytes as compared with nonprofessional APC.

A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12.

Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients.

Polyclonal CTL responses observed in melanoma patients vaccinated with dendritic cells pulsed with a MAGE-3.A1 peptide.

P304

337-343

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.22309

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6730620

http://www.w3.org/2001/XMLSchema#string

P698

17066423

http://www.w3.org/2001/XMLSchema#string

P921